Published in Nature on April 13, 1978
Evidence for two distinct classes of murine B cell growth factors with activities in different functional assays. J Exp Med (1983) 2.56
Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity. Proc Natl Acad Sci U S A (1988) 2.45
Production of a B cell growth-promoting activity, (DL)BCGF, from a cloned T cell line and its assay on the BCL1 B cell tumor. J Exp Med (1982) 2.22
Transcriptional regulation of the mu-delta heavy chain locus in normal murine B lymphocytes. J Exp Med (1984) 1.88
Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias. Am J Pathol (1983) 1.51
Pregnancy-related steroids are potential negative regulators of B lymphopoiesis. Proc Natl Acad Sci U S A (1994) 1.42
Identification of a fourth class of proteins linked to the murine major histocompatibility complex. Proc Natl Acad Sci U S A (1982) 1.27
Differential effect of B lymphocyte-induced maturation protein (Blimp-1) expression on cell fate during B cell development. J Exp Med (1998) 1.23
Characterization of mouse cellular deoxyribonucleic acid homologous to Abelson murine leukemia virus-specific sequences. Mol Cell Biol (1981) 1.17
Cancer dormancy: isolation and characterization of dormant lymphoma cells. Proc Natl Acad Sci U S A (1993) 1.14
Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants. Proc Natl Acad Sci U S A (1999) 1.06
The aryl hydrocarbon receptor interacts with ATP5α1, a subunit of the ATP synthase complex, and modulates mitochondrial function. Toxicol Appl Pharmacol (2011) 1.02
Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice. J Exp Med (1995) 1.02
Murine models of B-cell lymphomas: promising tools for designing cancer therapies. Adv Hematol (2012) 1.01
Acquisition of cell surface IgD after in vitro culture of neoplastic B cells from the murine tumor BCL1. J Exp Med (1980) 1.01
"Peptabody": a new type of high avidity binding protein. Proc Natl Acad Sci U S A (1997) 1.00
Gingival mononuclear cells from chronic inflammatory periodontal tissues produce interleukin (IL)-5 and IL-6 but not IL-2 and IL-4. Am J Pathol (1993) 0.99
Effect of lipopolysaccharide stimulation on the transcription and translation of messenger RNA for cell surface immunoglobulin M. J Exp Med (1982) 0.97
In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins. J Exp Med (1982) 0.96
Immunopathology of natural and experimental lymphomas induced by wild mouse leukemia virus. Am J Pathol (1981) 0.95
Processing at immunoglobulin polyadenylation sites in lymphoid cell extracts. EMBO J (1988) 0.93
Anaphylatoxin-mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune responses. J Exp Med (1982) 0.90
Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease. Blood (2015) 0.89
CD62L- memory T cells enhance T-cell regeneration after allogeneic stem cell transplantation by eliminating host resistance in mice. Blood (2012) 0.84
Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis. Clin Exp Immunol (2002) 0.83
Cytotoxic T cells specific for antigens expressed on surface immunoglobulin-positive cells. J Exp Med (1981) 0.82
H-40, an antigen controlled by an Igh linked gene and recognized by cytotoxic T lymphocytes. I. Genetic analysis of H-40 and distribution of its product on B cell tumors. J Exp Med (1984) 0.81
Induction of amplified synthesis and secretion of IgM by fusion of murine 'b lymphoma with myeloma cells. Proc Natl Acad Sci U S A (1979) 0.81
Expression of structurally diverse Qa-2-encoded molecules on the surface of cloned cytotoxic T lymphocytes. J Exp Med (1984) 0.80
Characterization of lymphocyte receptors for glycosaminoglycans. Immunology (1991) 0.79
Chemically linked phage idiotype vaccination in the murine B cell lymphoma 1 model. J Transl Med (2013) 0.78
BCL1, a murine model of prolymphocytic leukemia. I. Effect of splenectomy on growth kinetics and organ distribution. Am J Pathol (1981) 0.77
Regulation of B cell lymphomagenesis by a malignant Qal+ inducer T cell clone. J Exp Med (1984) 0.77
Stage transitions in B-lymphocyte differentiation correlate with limited variations in nuclear proteins. Proc Natl Acad Sci U S A (1991) 0.77
Secretion of idiotypic IgM by the mouse B-cell leukaemia (BCL1) occurs spontaneously in vitro and in vivo. Immunology (1985) 0.77
Path to clinical transplantation tolerance and prevention of graft-versus-host disease. Immunol Res (2014) 0.76
BCL1, a murine model of prolymphocytic leukemia. II. Morphology and ultrastructure. Am J Pathol (1981) 0.75
Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures. Mol Cell Proteomics (2017) 0.75
Enhancement of non-Candida antibody responses by Candida albicans cell wall glycoprotein. Infect Immun (1987) 0.75
The Role of Regulatory B Cell-Like Malignant Cells and Treg Cells in the Mouse Model of BCL1 Tumor Dormancy. PLoS One (2016) 0.75
Isolation of CD4- CD8- mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid. Nature (1989) 3.79
Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. J Exp Med (1977) 3.48
Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. Am J Transplant (2012) 2.46
Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J Exp Med (1999) 2.00
Identification and quantitation of thymus-derived lymphocytes in human peripheral blood. J Immunol (1974) 1.73
The relationship between surface immunoglobulin isotype and immune function of murine B lymphocytes. I. Surface immunoglobulin isotypes on primed B cells in the spleen. J Exp Med (1977) 1.71
Treatment of intractable rheumatoid arthritis with total lymphoid irradiation. N Engl J Med (1981) 1.69
Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome. Bone Marrow Transplant (2006) 1.67
Long-term survival of skin allografts in mice treated with fractionated total lymphoid irradiation. Science (1976) 1.66
Requirement for interactions of natural killer T cells and myeloid-derived suppressor cells for transplantation tolerance. Am J Transplant (2014) 1.63
Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships. Annu Rev Immunol (1984) 1.61
Safety of retroviral gene marking with a truncated NGF receptor. Nat Med (2003) 1.60
Initiation of antibody responses by different classes of lymphocytes. V. Fundamental changes in the physiological characteristics of virgin thymus-independent ("B") lymphocytes and "B" memory cells. J Exp Med (1972) 1.59
Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease. J Clin Invest (1976) 1.59
Characterization of a spontaneous murine B cell leukemia (BCL1). II. Tumor cell proliferation and IgM secretion after stimulation by LPS. J Immunol (1979) 1.58
Treatment of post-hematopoietic stem cell transplantation hemorrhagic cystitis with intravesicular sodium hyaluronate. Bone Marrow Transplant (2006) 1.57
Immune function cell surface characteristics and maturation of B cell subpopulations. Transplant Rev (1975) 1.55
CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: beta 2-microglobulin-dependent and independent forms. J Immunol (1998) 1.54
Immune specific production of interferon by human T cells in combined macrophage-lymphocyte cultures in response to Herpes simplex antigen. J Immunol (1975) 1.49
Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide. Ann Neurol (1993) 1.48
Fractionated total lymphoid irradiation as preparative immunosuppression in high risk renal transplantation: clinical and immunological studies. Ann Surg (1982) 1.44
Transplantation tolerance in adult rats using total lymphoid irradiation: permanent survival of skin, heart, and marrow allografts. J Exp Med (1978) 1.44
Low molecular weight heparin for Hickman catheter--induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation. Cancer (1992) 1.42
Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation. J Exp Med (1978) 1.40
Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals. Proc Natl Acad Sci U S A (1988) 1.39
Fludarabine-based protocol for human umbilical cord blood transplantation in children with Fanconi anemia. J Pediatr Hematol Oncol (1999) 1.39
Seroconversion in context. AIDS Care (2003) 1.38
Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma. J Immunother (2001) 1.38
Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease. Cancer (1975) 1.35
Maturation of B lymphocytes in the rat. I. Migration pattern, tissue distribution, and turnover rate of unprimed and primed B lymphocytes involved in the adoptive antidinitrophenyl response. J Exp Med (1973) 1.34
Characterization of a spontaneous murine B cell leukemia (BCL1). I. Cell surface expression of IgM, IgD, Ia, and FcR. J Immunol (1979) 1.33
Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice. J Immunol (2000) 1.33
Cell differentiation in the presence of cytochalasin B: studies on the "switch" to IgG secretion after polyclonal B cell activation. J Immunol (1979) 1.32
Immunobiology of a spontaneous murine B cell leukemia (BCL1). Immunol Rev (1979) 1.31
The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD. Tissue Antigens (2004) 1.31
Simultaneous expression of immunoglobulin mu and delta heavy chains by a cloned B-cell lymphoma: a single copy of the VH gene is shared by two adjacent CH genes. Proc Natl Acad Sci U S A (1982) 1.29
An in vitro line of the B cell tumor BCL1 can be activated by LPS to secrete IgM1. J Immunol (1980) 1.25
Studies of CD4- CD8- alpha beta bone marrow T cells with suppressor activity. J Immunol (1992) 1.25
The relationship between surface immunoglobulin isotype and immune function of murine B lymphocytes II. Surface immunoglobulin isotopes on unprimed B cells in the spleen. J Exp Med (1977) 1.23
Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study. Leukemia (2007) 1.22
Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity (2006) 1.22
Right atrial thrombi are related to indwelling central venous catheter position: insights into time course and possible mechanism of formation. Am Heart J (1998) 1.21
Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody. Proc Natl Acad Sci U S A (2000) 1.20
Maturation of B lymphocytes in the rat. II. Subpopulations of virgin B lymphocytes in the spleen and thoracic duct lymph. J Immunol (1975) 1.20
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood (2000) 1.19
Characterization of the spontaneous murine B cell leukemia (BCL1). III. Evidence for monoclonality by using an anti-idiotype antibody. J Immunol (1979) 1.18
Use of total lymphoid irradiation in tissue transplantation in mice. Transplant Proc (1977) 1.18
Chimerism, graft survival, and withdrawal of immunosuppressive drugs in HLA matched and mismatched patients after living donor kidney and hematopoietic cell transplantation. Am J Transplant (2015) 1.15
Transplantation tolerance after total lymphoid irradiation. Transplant Proc (1979) 1.15
Inhibition of T cells proliferation and SLE-like syndrome of MRL/1 mice by whole body or total lymphoid irradiation. J Immunol (1980) 1.14
Understanding Concerns About Treatment-as-Prevention Among People with HIV who are not Using Antiretroviral Therapy. AIDS Behav (2015) 1.13
Heterogeneous effects of IFN-gamma in adjuvant arthritis. J Immunol (1989) 1.12
Reversal of nzb/nzw disease with total lymphoid irradiation. J Exp Med (1979) 1.12
Subsets of transgenic T cells that recognize CD1 induce or prevent murine lupus: role of cytokines. J Exp Med (1998) 1.11
The changed balance of regulatory and naive T cells promotes tolerance after TLI and anti-T-cell antibody conditioning. Am J Transplant (2009) 1.11
Immunoglobulin class commitment exhibited by B lymphocytes separated according to surface isotype. J Immunol (1981) 1.10
Biological characteristics of T and B memory lymphocytes in the rat. J Exp Med (1973) 1.10
Evidence for mouse Th1- and Th2-like helper T cells in vivo. Selective reduction of Th1-like cells after total lymphoid irradiation. J Exp Med (1989) 1.09
Doctoring: University of California, Los Angeles. Acad Med (1998) 1.09
Surface Ig isotypes on cells responding to lipopolysaccharide by IgM and IgG secretion. J Immunol (1979) 1.08
Total lymphoid irradiation prevents diabetes mellitus in the Bio-Breeding/Worcester (BB/W) rat. Diabetes (1984) 1.08
Allograft tolerance after total lymphoid irradiation (TLI). Immunol Rev (1979) 1.07
Synergistic effects of combined immunosuppressive modulation. I. Unresponsiveness to dendritic cell-depleted renal allografts in dogs exposed to total-lymphoid irradiation. Transplantation (1988) 1.07
Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test. N Engl J Med (1976) 1.07
Natural suppressor (NS) cells found in the spleen of neonatal mice and adult mice given total lymphoid irradiation (TLI) express the null surface phenotype. J Immunol (1984) 1.05
Functional clonal deletion versus active suppression in transplantation tolerance induced by total-lymphoid irradiation. Transplantation (1985) 1.02
Mini-allografts: ongoing trials in humans. Bone Marrow Transplant (2000) 1.02
Initiation of primary antibody responses by both circulating and non-circulating lymphocytes. Nature (1968) 1.02
Total lymphoid and local joint irradiation in the treatment of adjuvant arthritis. Arthritis Rheum (1981) 1.01
An alternate pathway for T cell development supported by the bone marrow microenvironment: recapitulation of thymic maturation. J Exp Med (1998) 1.01
The relationship between surface immunoglobulin isotype and immune function of murine B lymphocytes. III. Expression of a single predominant isotype on primed and unprimed B cells. J Exp Med (1978) 1.01
Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide). Proc Natl Acad Sci U S A (1993) 1.00
Amelioration of diabetes in nonobese diabetic mice with advanced disease by linomide-induced immunoregulation combined with Reg protein treatment. Endocrinology (1998) 1.00
Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation. Hepatology (1993) 0.99
Alloantigen persistence in induction and maintenance of transplantation tolerance. J Exp Med (1987) 0.99
Induction of specific unresponsiveness to heart allografts in mongrel dogs treated with total lymphoid irradiation and antithymocyte globulin. J Immunol (1984) 0.99
Health care reform as perceived by first year medical students. J Community Health (1994) 0.99
Osmotic behavior of normal and leukemic lymphocytes. Blood (1975) 0.98
Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants. Tissue Antigens (2005) 0.98
Total lymphoid irradiation leads to transient depletion of the mouse thymic medulla and persistent abnormalities among medullary stromal cells. J Immunol (1988) 0.98
The use of total lymphoid irradiation (TLI) as immunosuppressive therapy for organ allotransplantation and autoimmune diseases. Int J Radiat Oncol Biol Phys (1981) 0.98
Heterogeneity of NK1.1+ T cells in the bone marrow: divergence from the thymus. J Immunol (1999) 0.98
Extrathymic maturation of alpha beta T cells from hemopoietic stem cells. J Immunol (1995) 0.98
Allogeneic bone marrow cells that facilitate complete chimerism and eliminate tumor cells express both CD8 and T-cell antigen receptor-alphabeta. Blood (2001) 0.97
Identification of an early T cell progenitor for a pathway of T cell maturation in the bone marrow. Proc Natl Acad Sci U S A (1999) 0.97
Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma. Bone Marrow Transplant (2000) 0.96